{
  "guideline": {
    "id": "PA166104876",
    "name": "Annotation of FDA Label for primaquine and G6PD",
    "source": "FDA",
    "version": 30,
    "url": "https://www.pharmgkb.org/labelAnnotation/PA166104876",
    "relatedChemicals": [
      {
        "id": "PA451103",
        "name": "primaquine",
        "symbol": null
      }
    ],
    "relatedGenes": [
      {
        "id": "PA28469",
        "name": "glucose-6-phosphate dehydrogenase",
        "symbol": "G6PD"
      }
    ],
    "recommendation": false
  },
  "recommendations": [
    {
      "id": "PA166312222",
      "name": "Recommendation Annotation PA166312222",
      "population": null,
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA451103",
          "name": "primaquine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452216481,
        "html": "<p>&quot;Primaquine should not be prescribed for patients with severe G6PD deficiency.&quot; See label for more information.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "G6PD": "Deficient with CNSHA"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166312223",
      "name": "Recommendation Annotation PA166312223",
      "population": null,
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA451103",
          "name": "primaquine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452216482,
        "html": "<p>&quot;In case of mild to moderate G6PD deficiency, a decision to prescribe primaquine must be based on an assessment of the risks and benefits...&quot; See label for more information.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "G6PD": "Deficient"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": true
    },
    {
      "id": "PA166314961",
      "name": "Recommendation Annotation PA166314961",
      "population": null,
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA451103",
          "name": "primaquine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452245500,
        "html": "<p>&quot;In case of mild to moderate G6PD deficiency, a decision to prescribe primaquine must be based on an assessment of the risks and benefits...&quot; See label for more information.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "G6PD": "Variable"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": true
    }
  ],
  "citations": [
    {
      "pmid": null,
      "title": "Drugs@FDA: Drug Product Primaquine Phosphate (Primaquine Phosphate), NDA008316, PD-Rx Pharmaceuticals, Inc.",
      "authors": [],
      "journal": null,
      "year": -1,
      "_sameAs": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=008316"
    }
  ],
  "version": "2024-02-29-20-19"
}